Pertuzumab a recombinantmonoclonal antibody act on extracellular dimerization domain II of HER2, it down regulated ligand - dependent HER2 hetrodimerizationleads to inhibition of tumor cell growth [11]. The gene discussed is ERBB2; the disease is neoplasm.